Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword or section
Like this
6Activity
0 of .
Results for:
No results containing your search query
P. 1
Atazanavir - Patent Landscape Report

Atazanavir - Patent Landscape Report

Ratings: (0)|Views: 276 |Likes:
Atazanavir is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. It is included in the WHO Model List of Essential Medicines (EML). This report examines the evolution of the patent environment protecting Atazanavir from the first filing of this compound in July 1995 by CIBA-GEIGY to the present filings. It also provides insight into best practice for probing the patent literature in the pharmaceutical area.
Atazanavir is an antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS. It is included in the WHO Model List of Essential Medicines (EML). This report examines the evolution of the patent environment protecting Atazanavir from the first filing of this compound in July 1995 by CIBA-GEIGY to the present filings. It also provides insight into best practice for probing the patent literature in the pharmaceutical area.

More info:

Categories:Business/Law
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

03/15/2013

pdf

text

original

 
Patent Landscape Report on
 Atazanavir
NOVEMBER 2011PATENT LANDSCAPE REPORTS PROJECT
 
The WIPO patent landscape report project isbased on the Development Agenda projectDA_19_30_31_01 “Developing Tools for  Access to Patent Information” describedin document CDIP/4/6, adopted by theCommittee on Development and IntellectualProperty (CDIP) at its fourth session heldfrom November 16 to November 20, 2009.
The purpose of each report is three fold :
It attempts to research and describethe patterns of patenting and innovation
activity related to specic technologies
in various domains such as health, foodand agriculture, climate change relatedtechnologies, and others.
WIPO attempts to collaborate for eachreport with institutional partners (IGOs,NGOs, public institutions of Member 
States) working in the respective eldand having an interest in a specic topic.
The collaborative work in the planning andevaluation phases may also serve as avehicle for these institutions to familiar-ize themselves with the utilization andexploitation of patent information andrelated issues of patent protection. WIPOwelcomes proposals for collaboration.
Each report also serves as an illustrativeexample for retrieving patent information
in the respective eld and how search
strategies may be tailored accordingly. Ittherefore includes detailed explanationsof the particular search methodology, thedatabases used and well documentedsearch queries that should ideally enablethe reader to conduct a similar search.Each report of this project is contracted out
to an external rm selected in a tendering
procedure. The tender is open to a limitednumber of bidders that were pre-selectedbased on their submission of an Expressionof Interest (EOI). WIPO invites the submis-
sion of further EOIs by qualied providers.
More Information on the project, the ongoingwork, and a compilation of reports published
also by other institutions is available at :
www.wipo.int/patentscope/en/programs/  patent_landscapes/pl_about.html 
For specific information, requests or 
proposals, please contact us at : patent.
information@wipo.int
 
 
1
Patent Landscape Report on Atazanavir 
A patent landscape report preparedfor theWorld Intellectual Property Organization (WIPO)by Thomson ReutersIP Solutions, IP Consulting Group
In cooperation with the Medicines Patent Pool (MPP)
 
November 2011

You're Reading a Free Preview

Download